Jiangsu Macro&Micro-Test Med-Tech Co Ltd – located in the Rudong High-tech Industrial Development Zone in Rudong county, Nantong, East China's Jiangsu province – is a high-tech firm focusing on new detection technologies and research, development and production of new in vitro diagnostic reagents.

It is also the first and only manufacturer of COVID-19 testing products in Rudong.

During the epidemic, the company successively developed products for nucleic acid testing, and antigen and antibody detection, providing strong support for epidemic prevention and control.

At present, a nucleic acid test result is still understood to be essential to confirm an infection of the COVID-19. With its advantage of a flexible application and being easy to operate, an antigen test is generally used for screening specific groups of people as a supplementary means.

The antigen testing kit produced by Macro&Micro-Test includes a nasal (pharyngeal) swab, an eluate, and test card. The result can be ready in 15 minutes. [Photo/WeChat account: rudongfb]

With its stable properties, the product has obtained CE certification from the European Union and is mainly being sold to Germany, France, Hungary and Austria. The total sales volume to date has exceeded 100 million kits.

At present, the daily production capacity is about 1 million kits, according to Wang Pengzhi, deputy general manager of the company.

The domestic registration certificate for the testing kit is underway. As soon as the certificate is issued, the firm is expected to swing into action to produce test kits to provide strong support for anti-epidemic work in China.

Employees at Jiangsu Macro&Micro-Test Med-Tech Co Ltd produce COVID-19 antigen test kits. [Photo/WeChat account: rudongfb]